Skip to main content
Top
Published in: Inflammation 2/2018

01-03-2018 | ORIGINAL ARTICLE

PI3K Is a Linker Between L-selectin and PSGL-1 Signaling to IL-18 Transcriptional Activation at the Promoter Level

Author: Jixian Luo

Published in: Inflammation | Issue 2/2018

Login to get access

Abstract

L-selectin and P-selectin glycoprotein ligand-1 (PSGL-1) are adhesion molecules which induce similar physiological events. Our previous paper showed that phosphatidylinositol 3-kinase (PI3K) played a crucial role in L-selectin- and PSGL-1-mediated F-actin redistribution and assembly during neutrophil rolling on E-selectin. However, it is not clear whether L-selectin and PSGL-1 induce other similar physiology events by PI3K. Here, we investigated the possibility of PI3K linking the signaling pathways of L-selectin and PSGL-1 to IL-18 transcription. We first demonstrated that L-selectin and PSGL-1 stimulation upregulated IL-18 transcription level in Jurkat cells. Then we found that PI3K inhibitor LY294002 reduced L-selectin- and PSGL-1-induced mRNA upregulation of IL-18 in Jurkat cells. Transfection of phosphatase and tensin homolog expressing plasmid inhibited the transcription level of IL-18. Therefore, PI3K is a signal linker between L-selectin and PSGL-1 in IL-18 transcriptional activation at the promoter level. To our knowledge, this is the first time to directly link PI3K to L-selectin- and PSGL-1-mediated IL-18 transcription, providing a foundation for intervention of PI3K-related inflammation.
Literature
1.
go back to reference van Buul, J.D., and P.L. Hordijk. 2004. Signaling in leukocyte transendothelial migration. Arteriosclerosis, Thrombosis, and Vascular Biology 24 (5): 824–833.CrossRefPubMed van Buul, J.D., and P.L. Hordijk. 2004. Signaling in leukocyte transendothelial migration. Arteriosclerosis, Thrombosis, and Vascular Biology 24 (5): 824–833.CrossRefPubMed
2.
go back to reference Alon, R., and M.L. Dustin. 2007. Force as a facilitator of integrin conformational changes during leukocyte arrest on blood vessels and antigen-presenting cells. Immunity 26 (1): 17–27.CrossRefPubMed Alon, R., and M.L. Dustin. 2007. Force as a facilitator of integrin conformational changes during leukocyte arrest on blood vessels and antigen-presenting cells. Immunity 26 (1): 17–27.CrossRefPubMed
3.
go back to reference Bruehl, R.E., K.L. Moore, D.E. Lorant, N. Borregaard, G.A. Zimmerman, R.P. McEver, and D.F. Bainton. 1997. Leukocyte activation induces surface redistribution of P-selectin glycoprotein ligand-1. Journal of Leukocyte Biology 61 (4): 489–499.CrossRefPubMed Bruehl, R.E., K.L. Moore, D.E. Lorant, N. Borregaard, G.A. Zimmerman, R.P. McEver, and D.F. Bainton. 1997. Leukocyte activation induces surface redistribution of P-selectin glycoprotein ligand-1. Journal of Leukocyte Biology 61 (4): 489–499.CrossRefPubMed
4.
go back to reference Abbal, C., M. Lambelet, D. Bertaggia, C. Gerbex, M. Martinez, A. Arcaro, M. Schapira, and O. Spertini. 2006. Lipid raft adhesion receptors and Syk regulate selectin-dependent rolling under flow conditions. Blood 108 (10): 3352–3359.CrossRefPubMed Abbal, C., M. Lambelet, D. Bertaggia, C. Gerbex, M. Martinez, A. Arcaro, M. Schapira, and O. Spertini. 2006. Lipid raft adhesion receptors and Syk regulate selectin-dependent rolling under flow conditions. Blood 108 (10): 3352–3359.CrossRefPubMed
5.
go back to reference Urzainqui, A., J.M. Serrador, F. Viedma, M. Yanez-Mo, A. Rodriguez, A.L. Corbi, J.L. Alonso-Lebrero, A. Luque, M. Deckert, J. Vazquez, et al. 2002. ITAM-based interaction of ERM proteins with Syk mediates signaling by the leukocyte adhesion receptor PSGL-1. Immunity 17 (4): 401–412.CrossRefPubMed Urzainqui, A., J.M. Serrador, F. Viedma, M. Yanez-Mo, A. Rodriguez, A.L. Corbi, J.L. Alonso-Lebrero, A. Luque, M. Deckert, J. Vazquez, et al. 2002. ITAM-based interaction of ERM proteins with Syk mediates signaling by the leukocyte adhesion receptor PSGL-1. Immunity 17 (4): 401–412.CrossRefPubMed
6.
go back to reference Ivetic, A., J. Deka, A. Ridley, and A. Ager. 2002. The cytoplasmic tail of L-selectin interacts with members of the ezrin-radixin-moesin (ERM) family of proteins: cell activation-dependent binding of moesin but not ezrin. The Journal of Biological Chemistry 277 (3): 2321–2329.CrossRefPubMed Ivetic, A., J. Deka, A. Ridley, and A. Ager. 2002. The cytoplasmic tail of L-selectin interacts with members of the ezrin-radixin-moesin (ERM) family of proteins: cell activation-dependent binding of moesin but not ezrin. The Journal of Biological Chemistry 277 (3): 2321–2329.CrossRefPubMed
7.
go back to reference Ivetic, A., O. Florey, J. Deka, D.O. Haskard, A. Ager, and A.J. Ridley. 2004. Mutagenesis of the ezrin-radixin-moesin binding domain of L-selectin tail affects shedding, microvillar positioning, and leukocyte tethering. The Journal of Biological Chemistry 279 (32): 33263–33272.CrossRefPubMed Ivetic, A., O. Florey, J. Deka, D.O. Haskard, A. Ager, and A.J. Ridley. 2004. Mutagenesis of the ezrin-radixin-moesin binding domain of L-selectin tail affects shedding, microvillar positioning, and leukocyte tethering. The Journal of Biological Chemistry 279 (32): 33263–33272.CrossRefPubMed
8.
go back to reference Chen, C., X. Shang, T. Xu, L. Cui, J. Luo, X. Ba, S. Hao, and X. Zeng. 2007. c-Abl is required for the signaling transduction induced by L-selectin ligation. European Journal of Immunology 37 (11): 3246–3258.CrossRefPubMed Chen, C., X. Shang, T. Xu, L. Cui, J. Luo, X. Ba, S. Hao, and X. Zeng. 2007. c-Abl is required for the signaling transduction induced by L-selectin ligation. European Journal of Immunology 37 (11): 3246–3258.CrossRefPubMed
9.
go back to reference Chen, C., X. Shang, L. Cui, T. Xu, J. Luo, X. Ba, and X. Zeng. 2008. L-selectin ligation-induced CSF-1 gene transcription is regulated by AP-1 in a c-Abl kinase-dependent manner. Human Immunology 69 (8): 501–509.CrossRefPubMed Chen, C., X. Shang, L. Cui, T. Xu, J. Luo, X. Ba, and X. Zeng. 2008. L-selectin ligation-induced CSF-1 gene transcription is regulated by AP-1 in a c-Abl kinase-dependent manner. Human Immunology 69 (8): 501–509.CrossRefPubMed
10.
go back to reference Luo, J., T. Xu, X. Wang, X. Ba, X. Feng, V. Deepak, and X. Zeng. 2010. PI3K is involved in L-selectin- and PSGL-1-mediated neutrophil rolling on E-selectin via F-actin redistribution and assembly. Journal of Cellular Biochemistry 110 (4): 910–919.CrossRefPubMed Luo, J., T. Xu, X. Wang, X. Ba, X. Feng, V. Deepak, and X. Zeng. 2010. PI3K is involved in L-selectin- and PSGL-1-mediated neutrophil rolling on E-selectin via F-actin redistribution and assembly. Journal of Cellular Biochemistry 110 (4): 910–919.CrossRefPubMed
11.
go back to reference Kalesnikoff, J., L.M. Sly, M.R. Hughes, T. Buchse, M.J. Rauh, L.P. Cao, V. Lam, A. Mui, M. Huber, and G. Krystal. 2003. The role of SHIP in cytokine-induced signaling. Reviews of Physiology, Biochemistry and Pharmacology 149: 87–103.CrossRefPubMed Kalesnikoff, J., L.M. Sly, M.R. Hughes, T. Buchse, M.J. Rauh, L.P. Cao, V. Lam, A. Mui, M. Huber, and G. Krystal. 2003. The role of SHIP in cytokine-induced signaling. Reviews of Physiology, Biochemistry and Pharmacology 149: 87–103.CrossRefPubMed
12.
go back to reference Kisseleva, M.V., M.P. Wilson, and P.W. Majerus. 2000. The isolation and characterization of a cDNA encoding phospholipid-specific inositol polyphosphate 5-phosphatase. The Journal of Biological Chemistry 275 (26): 20110–20116.CrossRefPubMed Kisseleva, M.V., M.P. Wilson, and P.W. Majerus. 2000. The isolation and characterization of a cDNA encoding phospholipid-specific inositol polyphosphate 5-phosphatase. The Journal of Biological Chemistry 275 (26): 20110–20116.CrossRefPubMed
13.
go back to reference Rohrschneider, L.R., J.F. Fuller, I. Wolf, Y. Liu, and D.M. Lucas. 2000. Structure, function, and biology of SHIP proteins. Genes & Development 14 (5): 505–520. Rohrschneider, L.R., J.F. Fuller, I. Wolf, Y. Liu, and D.M. Lucas. 2000. Structure, function, and biology of SHIP proteins. Genes & Development 14 (5): 505–520.
14.
go back to reference Stambolic, V., A. Suzuki, J.L. de la Pompa, G.M. Brothers, C. Mirtsos, T. Sasaki, J. Ruland, J.M. Penninger, D.P. Siderovski, and T.W. Mak. 1998. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95 (1): 29–39.CrossRefPubMed Stambolic, V., A. Suzuki, J.L. de la Pompa, G.M. Brothers, C. Mirtsos, T. Sasaki, J. Ruland, J.M. Penninger, D.P. Siderovski, and T.W. Mak. 1998. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95 (1): 29–39.CrossRefPubMed
15.
go back to reference Micallef, M.J., T. Ohtsuki, K. Kohno, F. Tanabe, S. Ushio, M. Namba, T. Tanimoto, K. Torigoe, M. Fujii, M. Ikeda, et al. 1996. Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production. European Journal of Immunology 26 (7): 1647–1651.CrossRefPubMed Micallef, M.J., T. Ohtsuki, K. Kohno, F. Tanabe, S. Ushio, M. Namba, T. Tanimoto, K. Torigoe, M. Fujii, M. Ikeda, et al. 1996. Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production. European Journal of Immunology 26 (7): 1647–1651.CrossRefPubMed
16.
go back to reference Ushio, S., M. Namba, T. Okura, K. Hattori, Y. Nukada, K. Akita, F. Tanabe, K. Konishi, M. Micallef, M. Fujii, et al. 1996. Cloning of the cDNA for human IFN-gamma-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. Journal of Immunology 156 (11): 4274–4279. Ushio, S., M. Namba, T. Okura, K. Hattori, Y. Nukada, K. Akita, F. Tanabe, K. Konishi, M. Micallef, M. Fujii, et al. 1996. Cloning of the cDNA for human IFN-gamma-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. Journal of Immunology 156 (11): 4274–4279.
17.
go back to reference Hunter, C.A., J. Timans, P. Pisacane, S. Menon, G. Cai, W. Walker, M. Aste-Amezaga, R. Chizzonite, J.F. Bazan, and R.A. Kastelein. 1997. Comparison of the effects of interleukin-1 alpha, interleukin-1 beta and interferon-gamma-inducing factor on the production of interferon-gamma by natural killer. European Journal of Immunology 27 (11): 2787–2792.CrossRefPubMed Hunter, C.A., J. Timans, P. Pisacane, S. Menon, G. Cai, W. Walker, M. Aste-Amezaga, R. Chizzonite, J.F. Bazan, and R.A. Kastelein. 1997. Comparison of the effects of interleukin-1 alpha, interleukin-1 beta and interferon-gamma-inducing factor on the production of interferon-gamma by natural killer. European Journal of Immunology 27 (11): 2787–2792.CrossRefPubMed
18.
go back to reference Zhu, Q., and T.D. Kanneganti. 2017. Cutting edge: distinct regulatory mechanisms control proinflammatory cytokines IL-18 and IL-1beta. Journal of Immunology 198 (11): 4210–4215.CrossRef Zhu, Q., and T.D. Kanneganti. 2017. Cutting edge: distinct regulatory mechanisms control proinflammatory cytokines IL-18 and IL-1beta. Journal of Immunology 198 (11): 4210–4215.CrossRef
19.
go back to reference Wang, H., M. Hua, S. Wang, J. Yu, C. Chen, X. Zhao, C. Zhang, C. Zhong, R. Wang, N. He, et al. 2017. Genetic polymorphisms of IL-18 rs1946518 and IL-1beta rs16944 are associated with prognosis and survival of acute myeloid leukemia. Inflammation Research 66 (3): 249–258.CrossRefPubMed Wang, H., M. Hua, S. Wang, J. Yu, C. Chen, X. Zhao, C. Zhang, C. Zhong, R. Wang, N. He, et al. 2017. Genetic polymorphisms of IL-18 rs1946518 and IL-1beta rs16944 are associated with prognosis and survival of acute myeloid leukemia. Inflammation Research 66 (3): 249–258.CrossRefPubMed
20.
go back to reference Pui, C.H., M.V. Relling, and J.R. Downing. 2004. Acute lymphoblastic leukemia. The New England Journal of Medicine 350 (15): 1535–1548.CrossRefPubMed Pui, C.H., M.V. Relling, and J.R. Downing. 2004. Acute lymphoblastic leukemia. The New England Journal of Medicine 350 (15): 1535–1548.CrossRefPubMed
21.
go back to reference Alexandrakis, M.G., F.H. Passam, K. Sfiridaki, J. Moschandrea, C. Pappa, D. Liapi, E. Petreli, P. Roussou, and D.S. Kyriakou. 2004. Interleukin-18 in multiple myeloma patients: serum levels in relation to response to treatment and survival. Leukemia Research 28 (3): 259–266.CrossRefPubMed Alexandrakis, M.G., F.H. Passam, K. Sfiridaki, J. Moschandrea, C. Pappa, D. Liapi, E. Petreli, P. Roussou, and D.S. Kyriakou. 2004. Interleukin-18 in multiple myeloma patients: serum levels in relation to response to treatment and survival. Leukemia Research 28 (3): 259–266.CrossRefPubMed
22.
go back to reference Liu, Y., Z.P. Han, S.S. Zhang, Y.Y. Jing, Bu XX, C.Y. Wang, K. Sun, G.C. Jiang, X. Zhao, R. Li, et al. 2011. Effects of inflammatory factors on mesenchymal stem cells and their role in the promotion of tumor angiogenesis in colon cancer. The Journal of Biological Chemistry 286 (28): 25007–25015.CrossRefPubMedPubMedCentral Liu, Y., Z.P. Han, S.S. Zhang, Y.Y. Jing, Bu XX, C.Y. Wang, K. Sun, G.C. Jiang, X. Zhao, R. Li, et al. 2011. Effects of inflammatory factors on mesenchymal stem cells and their role in the promotion of tumor angiogenesis in colon cancer. The Journal of Biological Chemistry 286 (28): 25007–25015.CrossRefPubMedPubMedCentral
23.
go back to reference Reynaud, D., E. Pietras, K. Barry-Holson, A. Mir, M. Binnewies, M. Jeanne, O. Sala-Torra, J.P. Radich, and E. Passegue. 2011. IL-6 controls leukemic multipotent progenitor cell fate and contributes to chronic myelogenous leukemia development. Cancer Cell 20 (5): 661–673.CrossRefPubMedPubMedCentral Reynaud, D., E. Pietras, K. Barry-Holson, A. Mir, M. Binnewies, M. Jeanne, O. Sala-Torra, J.P. Radich, and E. Passegue. 2011. IL-6 controls leukemic multipotent progenitor cell fate and contributes to chronic myelogenous leukemia development. Cancer Cell 20 (5): 661–673.CrossRefPubMedPubMedCentral
24.
go back to reference Uzan, B., S. Poglio, B. Gerby, C.L. Wu, J. Gross, F. Armstrong, J. Calvo, X. Cahu, C. Deswarte, F. Dumont, et al. 2014. Interleukin-18 produced by bone marrow-derived stromal cells supports T-cell acute leukaemia progression. EMBO Molecular Medicine 6 (6): 821–834.PubMedPubMedCentral Uzan, B., S. Poglio, B. Gerby, C.L. Wu, J. Gross, F. Armstrong, J. Calvo, X. Cahu, C. Deswarte, F. Dumont, et al. 2014. Interleukin-18 produced by bone marrow-derived stromal cells supports T-cell acute leukaemia progression. EMBO Molecular Medicine 6 (6): 821–834.PubMedPubMedCentral
25.
go back to reference Ahn, I.E., Ju JH, S.Y. Lee, J.S. Park, Oh. HJ, H.R. Kim, S.H. Lee, S.H. Park, H.Y. Kim, and M.L. Cho. 2012. Upregulation of stromal cell-derived factor by IL-17 and IL-18 via a phosphatidylinositol 3-kinase-dependent pathway. Scandinavian Journal of Immunology 76 (4): 433–439.CrossRefPubMed Ahn, I.E., Ju JH, S.Y. Lee, J.S. Park, Oh. HJ, H.R. Kim, S.H. Lee, S.H. Park, H.Y. Kim, and M.L. Cho. 2012. Upregulation of stromal cell-derived factor by IL-17 and IL-18 via a phosphatidylinositol 3-kinase-dependent pathway. Scandinavian Journal of Immunology 76 (4): 433–439.CrossRefPubMed
Metadata
Title
PI3K Is a Linker Between L-selectin and PSGL-1 Signaling to IL-18 Transcriptional Activation at the Promoter Level
Author
Jixian Luo
Publication date
01-03-2018
Publisher
Springer US
Published in
Inflammation / Issue 2/2018
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-017-0711-5

Other articles of this Issue 2/2018

Inflammation 2/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.